High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021

Kavya Pathak, Claire Narang, Thomas J. Hwang, Juan Espinoza, Florence T. Bourgeois

JAMA Pediatrics · 2022 · 16 citations · 2 references

DOIFull text

Open access

Concepts

Abstract

This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.

References

2